Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Coherus Oncology Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
TriSalus Life Sciences Inc. June 12, 2025100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 5, 2026 | Coherus Oncology Inc. | Grant or award | +30,000 | — | — |
| May 15, 2026 | TriSalus Life Sciences Inc. | Open-market purchase | +60,000 | $2.53 | $151,800 |
| May 14, 2026 | TriSalus Life Sciences Inc. | Grant or award | +37,602 | — | — |
| May 14, 2026 | TriSalus Life Sciences Inc. | Grant or award | +34,226 | — | — |
| May 23, 2025 | Coherus Oncology Inc. | Open-market sale | −99,988 | $0.74 | $73,991 |
| Dec 17, 2024 | TriSalus Life Sciences Inc. | Grant or award | +25,188 | $3.97 | $99,996 |
| Nov 22, 2024 | TriSalus Life Sciences Inc. | Open-market purchase | +5,000 | $4.55 | $22,750 |
| Nov 21, 2024 | TriSalus Life Sciences Inc. | Open-market purchase | +8,687 | $4.44 | $38,570 |
| Nov 20, 2024 | TriSalus Life Sciences Inc. | Open-market purchase | +2,040 | $4.16 | $8,486 |
| Feb 9, 2024 | Coherus Oncology Inc. | Gift | −99,988 | — | — |
| Feb 9, 2024 | Coherus Oncology Inc. | Gift | +99,988 | — | — |
| Feb 1, 2024 | Coherus Oncology Inc. | Option exercise | +14,997 | $1.67 | $25,045 |
| Feb 1, 2024 | Coherus Oncology Inc. | Option exercise | +44,991 | $1.67 | $75,135 |
Questions about Mats Wahlstrom
What boards is Mats Wahlstrom on?
Mats Wahlstrom sits on the boards of Coherus Oncology Inc. and TriSalus Life Sciences Inc.
How long has Mats Wahlstrom served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.